How to bring innovation to the drug development space

How to bring innovation to the drug development space

Innovation is not only part of InnoSer’s name but is central to its activities. We believe, the solution for the continuously high drug attrition rates resides in addressing the problem already at the preclinical stages of drug development. More specifically, we aim...
Nano+ Project Ends With Promising Results

Nano+ Project Ends With Promising Results

Currently with no known cure, Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. InnoSer has recently finished a project with promising results in understanding altered...
A day in the life of InnoSer Oncology Study Director Kim Frederix

A day in the life of InnoSer Oncology Study Director Kim Frederix

To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...
InnoSers Ongoing Commitment to the 3R’s

InnoSers Ongoing Commitment to the 3R’s

Throughout modern medicine animal testing has played a critical role in the development of drugs, vaccines, and surgical techniques. These studies have enabled us to save countless lives and build upon research to ultimately cure patients. Aiming to accelerate the...
Quality Management At InnoSer Services

Quality Management At InnoSer Services

As InnoSer transitions from the startup to scale up phase in its journey, it is also taking a number of steps to ascertain its quality management ambitions. Having dedicated personnel, expanding our current list of certifications, organizing formal audits and...
BlastomaBrain: New in vitro platform for oncology drug development

BlastomaBrain: New in vitro platform for oncology drug development

One of the greatest challenges in drug development is ensuring that the safety and efficacy results from early stages (i.e. from tests on cultured cells or animal models) translate well to administrating the drugs to humans. The gap between the results from these...